This article, in support of “OncoPRO,” highlights the early responsiveness to patient symptoms preventing adverse downstream consequences due to integration of patient-reported outcomes in oncology care.
Citation Information:
Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, Schrag D. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. JAMA. 2017 Jul 11;318(2):197-198. doi: 10.1001/jama.2017.7156. PMID: 28586821; PMCID: PMC5817466. https://pubmed.ncbi.nlm.nih.gov/28586821/